This document provides an overview of evidence-based physical diagnosis. It discusses how diagnosis has evolved from being based primarily on physical examination findings a century ago to now often relying on technological tests. However, physical examination is still important for diagnoses that can only be made at the bedside. The goals are to define evidence-based physical diagnosis and demonstrate how concepts in epidemiology, biostatistics and probability are applied. It also reviews the diagnostic process and provides definitions for diagnostic test statistics like sensitivity, specificity, and predictive values. Key concepts in pre-test and post-test probability are introduced as well.
Journal of Immune Research is a peer-reviewed, open access journal published by Austin Publishers. It provides easy access to high quality Manuscripts in all related aspects of medical research on immune response, immune deficiency, immune system diseases and immune system boosters. The journal focuses upon the all the related aspects of biological structures and processes occurring within an organism to protect against diseases by fighting a wide variety of agents, known as pathogens, from viruses to parasitic worms, and distinguish them from the organism's own healthy tissue.
Austin Publishing Group is a successful host of more than hundred peer reviewed, open access journals in various fields of science and medicine with intent to bridge the gap between academia and research access.
Journal of Immune Research accepts original research articles, review articles, case reports, mini reviews, rapid communication, opinions and editorials on all related aspects of medical research on immune response, immune deficiency, immune system diseases and immune system boosters.
Journal of Immune Research is a peer-reviewed, open access journal published by Austin Publishers. It provides easy access to high quality Manuscripts in all related aspects of medical research on immune response, immune deficiency, immune system diseases and immune system boosters. The journal focuses upon the all the related aspects of biological structures and processes occurring within an organism to protect against diseases by fighting a wide variety of agents, known as pathogens, from viruses to parasitic worms, and distinguish them from the organism's own healthy tissue.
Austin Publishing Group is a successful host of more than hundred peer reviewed, open access journals in various fields of science and medicine with intent to bridge the gap between academia and research access.
Journal of Immune Research accepts original research articles, review articles, case reports, mini reviews, rapid communication, opinions and editorials on all related aspects of medical research on immune response, immune deficiency, immune system diseases and immune system boosters.
Lung Poorly differentiated Adenocarcinoma with Cerebral Metastasesasclepiuspdfs
A 61-year-old man was transferred to our hospital with dizziness and gait disturbance that had progressed over the preceding 2 weeks. Four weeks before presentation, he had presented to fever clinics with hemoptysis and fever and received a diagnose of mild Coronavirus disease 2019 pneumonia by nucleic acid test. Chest computed tomography (CT) scan showed the neoplasm in the left upper lung [Figure 1a and b], and findings on CT-guided percutaneous lung biopsy were consistent with poorly differentiated adenocarcinoma, which was one of non-small cell lung cancer (NSCLC).
Convalescent Plasma and COVID-19: Ancient Therapy Re-emergedasclepiuspdfs
Convalescent plasma has again re-emerged as a therapy during coronavirus disease (COVID-19) outbreaks currently use as a prophylactic or an interventional treatment in infected patients. Convalescent plasma has been used in the 20th century confronting different infectious diseases where there was no other therapy available. Conceivably, this convalescent plasma therapy tends to be proving a game-changing treatment in some COVID-19 patients and could support treatment, in addition to the current interventions before other developed therapies are available for the population.
Journal club - Disease progression in hemodynamically stable patients present...Farooq Khan
Critical appraisal of:
Glickman SW et al. Disease Progression in Hemodynamically Stable Patients Presenting to the Emergency Department With Sepsis. Acad Emerg Med. 2010 17:383-90
Interactive quiz on early goal-directed therapy, surviving sepsis guidelines and EBM topic of prognosis studies.
Journal Club presentation on Outbreak Investigation Study Kunal Modak
The following presentation is based on: Concurrent Multiple Outbreaks of Varicella, Rubeola,
German Measles Outbreak in Unvaccinated Children of
Co-Educational Mount Carmel Senior Secondary School,
Thakurdwara Palampur of Northern Himachal, India
Drs. Lorenzen and Barlock’s CMC X-Ray Mastery Project: October CasesSean M. Fox
Drs. Breeanna Lorenzen and Travis Barlock are Emergency Medicine Residents and interested in medical education. With the guidance of Dr. Michael Gibbs, a notable Professor of Emergency Medicine, they aim to help augment our understanding of emergent imaging. Follow along with the EMGuideWire.com team as they post these educational, self-guided radiology slides. This set will cover:
- Lobar Pneumonia
- Necrotizing Pneumonina
- PCP Pneumonia with Pneumatocele
- Pneumothorax
- Pleural Effusion
- Parapneumonic Effusion
- Aortic Transection
- Lung Mass
- ARDS
Gregg P. Skall, J.D. Counsel, National Capital Lyme and Tick-borne Disease Association Member, Womble Carlyle Sandridge & Rice, PLL, attended the Workshop on the Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-borne Diseases: the Short-Term and Long-Term Outcomes and gave the following presentation: Addressing the Gaps in Scientific Research on Lyme and Other Tick-Borne Diseases - A Patient Perspective.
Lung Poorly differentiated Adenocarcinoma with Cerebral Metastasesasclepiuspdfs
A 61-year-old man was transferred to our hospital with dizziness and gait disturbance that had progressed over the preceding 2 weeks. Four weeks before presentation, he had presented to fever clinics with hemoptysis and fever and received a diagnose of mild Coronavirus disease 2019 pneumonia by nucleic acid test. Chest computed tomography (CT) scan showed the neoplasm in the left upper lung [Figure 1a and b], and findings on CT-guided percutaneous lung biopsy were consistent with poorly differentiated adenocarcinoma, which was one of non-small cell lung cancer (NSCLC).
Convalescent Plasma and COVID-19: Ancient Therapy Re-emergedasclepiuspdfs
Convalescent plasma has again re-emerged as a therapy during coronavirus disease (COVID-19) outbreaks currently use as a prophylactic or an interventional treatment in infected patients. Convalescent plasma has been used in the 20th century confronting different infectious diseases where there was no other therapy available. Conceivably, this convalescent plasma therapy tends to be proving a game-changing treatment in some COVID-19 patients and could support treatment, in addition to the current interventions before other developed therapies are available for the population.
Journal club - Disease progression in hemodynamically stable patients present...Farooq Khan
Critical appraisal of:
Glickman SW et al. Disease Progression in Hemodynamically Stable Patients Presenting to the Emergency Department With Sepsis. Acad Emerg Med. 2010 17:383-90
Interactive quiz on early goal-directed therapy, surviving sepsis guidelines and EBM topic of prognosis studies.
Journal Club presentation on Outbreak Investigation Study Kunal Modak
The following presentation is based on: Concurrent Multiple Outbreaks of Varicella, Rubeola,
German Measles Outbreak in Unvaccinated Children of
Co-Educational Mount Carmel Senior Secondary School,
Thakurdwara Palampur of Northern Himachal, India
Drs. Lorenzen and Barlock’s CMC X-Ray Mastery Project: October CasesSean M. Fox
Drs. Breeanna Lorenzen and Travis Barlock are Emergency Medicine Residents and interested in medical education. With the guidance of Dr. Michael Gibbs, a notable Professor of Emergency Medicine, they aim to help augment our understanding of emergent imaging. Follow along with the EMGuideWire.com team as they post these educational, self-guided radiology slides. This set will cover:
- Lobar Pneumonia
- Necrotizing Pneumonina
- PCP Pneumonia with Pneumatocele
- Pneumothorax
- Pleural Effusion
- Parapneumonic Effusion
- Aortic Transection
- Lung Mass
- ARDS
Gregg P. Skall, J.D. Counsel, National Capital Lyme and Tick-borne Disease Association Member, Womble Carlyle Sandridge & Rice, PLL, attended the Workshop on the Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-borne Diseases: the Short-Term and Long-Term Outcomes and gave the following presentation: Addressing the Gaps in Scientific Research on Lyme and Other Tick-Borne Diseases - A Patient Perspective.
EBM is the practice of integrating individual clinical expertise with the best available clinical evidence from systematic research to maximize the quality and quantity of life for individual patients.
In the era of modern technology, health care delivery system involves so many different personnel and specialties that the caregiver must have an understanding and working knowledge of other professional endeavors, including the role of diagnostic evaluation.
Basically, laboratory and diagnostic tests are tools by and of themselves, they are not therapeutic.
In conjunction with a pertinent history and physical examination, these tests can confirm a diagnosis or provide valuable information about a patient status and response to therapy.
In addition to these, laboratory findings are essential for epidemiological surveillance and research purposes.
If the entire network of a laboratory service is to be effectively utilized and contribute to health care and disease prevention, every member of its work force need to:
Understand the role of the laboratory and its contribution to the nation’s health service;
Appreciate the need to involve all members in the provision of health service;
Follow professional ethics and code of conduct;
Experience job satisfaction and have professional loyalty.
Medical laboratory science is a complex field embracing a number of different disciplines such as
Microbiology,
Hematology,
Clinical Chemistry,
Urinalysis,
Immunology,
Serology,
Histopathology,
Immunohematology and
Molecular biology and others
Principles of diseses outbreak.in our societypptxw2tz2qrqxd
Principles of disease outbreak involve understanding the epidemiological factors that contribute to the spread of infectious diseases within a population. Key principles include:
1. Pathogen characteristics: Understanding the agent causing the disease, including its mode of transmission, incubation period, infectious dose, and virulence, is crucial for predicting its spread.
2. Host factors: Factors such as immunity, susceptibility, genetic predisposition, and behavior influence an individual's likelihood of contracting and spreading the disease.
3. Environmental factors: Environmental conditions, including climate, geography, sanitation, and population density, can facilitate or impede the transmission of diseases.
4. Transmission dynamics: Diseases can spread through various modes of transmission, including direct contact, droplet transmission, airborne transmission, vector-borne transmission, and fomite transmission.
5. Surveillance and monitoring: Timely and accurate surveillance systems are essential for detecting outbreaks, monitoring disease trends, and implementing control measures effectively.
6. Intervention strategies: Implementing interventions such as vaccination, quarantine, isolation, hygiene practices, vector control, and public health education can help prevent and control disease outbreaks.
7. Public health response: Coordinated efforts among healthcare providers, public health agencies, governments, and communities are necessary to respond promptly to disease outbreaks, mitigate their impact, and prevent further transmission.
Similar to Evidence-Based Physical Diagnosis_Lect. 1_ What is Evidence-Based Physical Diagnosis (20)
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Evidence-Based Physical Diagnosis_Lect. 1_ What is Evidence-Based Physical Diagnosis
1. Lecture 1:
What Is Evidence-Based Physical Diagnosis?
Marc Imhotep Cray, M.D.
Evidence-Based
Physical Diagnosis
2. Marc Imhotep Cray, M.D.
Goals
2
The goals of this presentation are
To elucidate the term evidence-based physical diagnosis.
To provide the learner with a first-layer understanding
modern-day physical diagnosis.
To demonstrate how concepts in basic epidemiology,
biostatistics and probability serve as requisites to
applying clinical epidemiology, evidence-based medicine
and thus, evidence-based physical diagnosis in core
clerkships.
3. Marc Imhotep Cray, M.D.
“Icebreaker Admonition”
3
“Read with two objectives: First to acquaint yourself with
the current knowledge on the subject and the steps by
which it has been reached; and secondly, and more
important, read to understand and analyze your cases.”
From: LeBlond RF, et al. DeGowin’s Diagnostic Examination, 10th Ed. New York:
McGraw-Hill Education, 2015; xxxi.
Originally: Sir William Osler
“The Student Life”
4. Marc Imhotep Cray, M.D.
Why is Diagnosis Important?
4
Medical history and physical examination (H&P) are
basis for diagnostic hypothesis generation the first
step in the diagnostic process
Accurate Dx precedes three tasks central to healing
professions: explanation, prognostication & therapy
These three tasks provide answers to patient’s three
fundamental questions:
1. What is happening to me and why?
2. What does this mean or my future?
3. What can be done about it, how will that change my future?
5. Marc Imhotep Cray, M.D.
Why is Diagnosis Important cont’d.
5
Failure to pursue a Dx may permit a disease to
progress from curable to incurable
Contrastly, for many complaints, in otherwise healthy
people w no alarm Sx or Sn a good prognosis can be
determined w/o knowing exact cause of complaint
For example, an upper respiratory infection (URI)
o An experienced clinician can reassure pt. further testing is
unnecessary and will not change Px or Tx
6. Marc Imhotep Cray, M.D.
Why is Diagnosis Important cont’d.
6
It takes…
Experience,
Knowledge of the medical literature,
Good judgment, and
Understanding of fundamentals of clinical
epidemiology and decision making
…to determine when pursuit of specific Sx & Sn is
warranted
Note: For a first-rate review of principles of epidemiology, see Fletcher et al.
[Fletcher RH, Fletcher SW, Fletcher GS. Clinical Epidemiology, the Essentials. 5th
ed. Baltimore, MD: Lippincott, Williams & Wilkens, 2012].
7. Marc Imhotep Cray, M.D.
Review of Diagnostic process:
(9 Sequential Steps)
7
Step 1: Take a History: Elicit symptoms and a timeline; begin a
problem list.
Step 2: Develop Hypotheses: Generate a mental list of anatomic sites
of disease, pathophysiologic processes, and diseases that might
produce the symptoms.
Step 3: Perform a Physical Examination: Look for signs of physiologic
processes and diseases suggested by history, and identify new
findings for problem list.
Step 4: Make a Problem List: List ALL problems found during history
and PE that require an explanation.
8. Marc Imhotep Cray, M.D.
Diagnostic process steps cont’d.
8
Step 5: Generate a Differential Diagnosis: List most probable
diagnostic hypotheses with an estimate of their pretest
probabilities.
Step 6: Test the Hypotheses: Select laboratory tests, imaging
studies, and other procedures with appropriate likelihood ratios to
evaluate your hypotheses.
Step 7: Modify Your Differential Diagnosis: Use test results to
evaluate your hypotheses, eliminating some, adding others, and
adjusting probabilities.
Step 8: Repeat Steps 1 to 7: Reiterate your process until you have
reached a diagnosis or decided that a definite diagnosis is neither
likely nor necessary.
9. Marc Imhotep Cray, M.D.
Diagnostic process steps cont’d.
9
Step 9: Make the Diagnosis or Diagnoses: When tests of your
hypotheses are of sufficient certainty that they meet your stopping
rule you have reached a diagnosis.
If uncertain, consider a provisional diagnosis or watchful
waiting.
Decide whether more investigation (return to Step l),
consultation, treatment, or watchful observation is best course
based upon severity of illness, prognosis, and comorbidities.
To learn more: LeBlond RF, et al. Part 1: The Diagnostic Framework. In: DeGowin’s
Diagnostic Examination, 9th Ed. New York: McGraw-Hill Education, 2009; 1-47.
10. Marc Imhotep Cray, M.D.
Diagnosis
10
When clinicians diagnose disease, their intent is to place patient’s
experience into a particular category (or diagnosis) a process
implying specific pathogenesis, prognosis, and treatment
This procedure allows clinicians to explain what is happening to patients
and to identify best way to restore pt’s health
A century ago, such categorization of disease rested almost
entirely on empiric observation—what clinicians saw, heard, and
felt at patient’s bedside
almost all diagnoses were based on traditional physical examination
11. Marc Imhotep Cray, M.D.
Diagnosis cont’d.
11
For example, if patients presented a century ago w
complaints of fever and cough, Dx of lobar
pneumonia rested on presence of characteristic PE
findings of pneumonia =
fever, tachycardia, tachypnea, grunting respirations, cyanosis,
↓ excursion of affected side, dullness to percussion, ↑ tactile
fremitus, ↓ breath sounds (later bronchial breath sounds),
abnormalities of vocal resonance (bronchophony, pectoriloquy,
and egophony), and crackles
o If findings were absent pt. did not have pneumonia
• Chest radiography played no role in diagnosis b/c it was not widely
available until early 1900s
12. Marc Imhotep Cray, M.D.
Diagnosis cont’d.
12
Modern medicine, of course, relies on technology much more
than medicine did a century ago (to our patients’ advantage)
and for many modern categories of disease, diagnostic standard
is a technologic test
For example, if patients present today with fever and cough
Dx of pneumonia is based on presence of an infiltrate on chest
radiograph
Similarly, Dx of systolic murmurs depends on echocardiography
and that of ascites on abdominal ultrasonography
o In these disorders, clinician’s principal interest is result of technologic
test and decisions about Tx depend much more on tech result
than on,
o whether pt. exhibits egophony, radiation of murmur into neck, or
shifting dullness
13. Marc Imhotep Cray, M.D.
Dx a Century Ago
13
McGee S, Steven R. Evidence-based Physical Diagnosis, 4th Ed. Philadelphia, PA: Elsevier, 2018; Fig..1.1, 2.
“EVOLUTION OF THE DIAGNOSTIC STANDARD”…
14. Marc Imhotep Cray, M.D.
Dx in Modern Times
14
McGee S, Steven R. Evidence-based Physical Diagnosis, 4th Ed. Philadelphia,
PA: Elsevier, 2018; Fig..1.1, 2.
One century ago, most Dx were
defined by bedside observation,
whereas
Today technologic standards have a
much greater diagnostic role
Nonetheless, there are many
examples today of Dx based solely
on bedside findings (Ex. appear in
large gray shaded box)
Evidence-based physical diagnosis, on
other hand, principally addresses
those Dx defined by technologic
standards b/c it identifies those
traditional findings that accurately
predict result of technologic test
…“EVOLUTION OF THE DIAGNOSTIC STANDARD”
15. Marc Imhotep Cray, M.D.
Evidence-based medicine
15
EBM is a modern term for application of clinical
epidemiology to care of patients it includes:
Formulating specific “answerable” clinical questions,
Finding best available research evidence bearing on those
questions,
Judging evidence for its validity, and
Integrating critical appraisal w clinician’s expertise & patient’s
situation and values
See previous lecture: Introduction to Evidence Based Medicine (EBM) .Ppt
16. Marc Imhotep Cray, M.D.
Dx in Modern Times cont’d.
16
Reliance on technology creates tension for medical
students* b/c they spend hours mastering
traditional exam yet later learn (when first appearing
wards) traditional exam pales in importance compared
to technology
A realization prompting a fundamental question:
o What is true diagnostic value of traditional physical
examination? Is it outdated and best discarded? Is it completely
accurate and underutilized? Is the truth somewhere between
these two extremes?
* This tension applies most in Western and other
highly technologically reliant and wealthy societies.
17. Marc Imhotep Cray, M.D.
Dx in Modern Times cont’d.
17
“EVOLUTION OF THE DIAGNOSTIC STANDARD” discussed above indicates
Dx today is split into two parts
For some categories of disease diagnostic standard still
remains empiric observation— what clinician sees, hears, and
feels—just as it was for all diagnoses a century ago
For example, how does a clinician know pt. has cellulitis?
Ans: Only way is to go to patient’s bedside and observe fever
and localized bright erythema, warmth, swelling, and
tenderness on leg
o There is no other way to make this diagnosis (technologic or not)
18. Marc Imhotep Cray, M.D. 18
NB: The purpose of the follow snippet of concepts
in basic epidemiology, biostatistics and probability
are entirely select, and only intended to support
understanding of how these concepts are applied
in clinical epidemiology, evidence-based medicine
and thus, evidence-based physical diagnosis.
To learn more student is referred to Public Health Sciences lectures
and the Sociology, Epidemiology/Population Health (SPH) &
Interpretation of the Medical Literature (EBM) cloud folders.
“Understanding the Evidence”
19. Marc Imhotep Cray, M.D.
Biostatistics Definitions
19
Incidence: The number of new cases of a disease in a population
over a specific period of time (=longitudinal)
Prevalence: The total number of people in a population affected
by a condition at one point in time (=cross-sectional)
Duration relates incidence to prevalence
For example:
Upper respiratory infections (URIs) have a high incidence every year
during winter months but a low prevalence b/c most URIs resolve
quickly
Contrastly,
Diabetes mellitus (DM) has a relatively low incidence but high
prevalence b/c a patient who has diabetes has it for life
20. Marc Imhotep Cray, M.D.
Statistics for Diagnostic Tests
20
True positive (Tp): Disease is present and diagnostic test is
positive a correct result
True negative (Tn): Disease is absent and diagnostic test is
negative a correct result
False positive (Fp): Disease is absent and diagnostic test is
positive an incorrect result
False negative (Fn): Disease is present and diagnostic test is
negative an incorrect result
21. Marc Imhotep Cray, M.D.
Statistics for Diagnostic Tests:
Sensitivity
21
Sensitivity: Given disease is present, probability that test will be
positive
Stated another way, sensitivity is ability of a test to become
positive in presence of the disease
It is defined as Tp/(Tp + Fn) or Tp/(total number of people
with disease)
Sensitive tests are useful for screening b/c there are few false
negatives
A highly sensitive test can, therefore, rule out the disease
o Consider the mnemonic SN-N-OUT= for a test that is SeNsitive, a
Negative result rules OUT a disease
22. Marc Imhotep Cray, M.D.
Statistics for Diagnostic Tests:
Sensitivity cont’d.
22
Example: An HIV test with 98% sensitivity means that, when a
disease is present, it will be detected 98% of time
Example: Consider a test that was positive 100% of time
regardless of presence or absence of disease
It would technically have 100% sensitivity b/c it would be
positive in all patients with disease (but would be clinically
useless b/c it would be positive in all patients without
disease, too)
o Therefore, sensitivity is not whole picture when it comes to test
characteristics specificity is also important
23. Marc Imhotep Cray, M.D.
Statistics for Diagnostic Tests
23
Specificity: Given disease is absent, probability that test will be
negative
Stated another way specificity is ability of a test to remain
negative in absence of disease
It is defined as Tn/(Tn + Fp) or Tn/(total number of people
without disease)
Tests with high specificity are useful to confirm a diagnosis b/c
there are few false positives
A highly specific test can, therefore, rule in the disease
o Consider the mnemonic SP-P-IN—for a test that is SPecific, a Positive
result rules IN a disease
For Example: An HIV test with 98% specificity means that, when a disease is
absent, test will be negative 98% of time
24. Marc Imhotep Cray, M.D.
Statistics for Diagnostic Tests:
PPV & NPV
24
Positive Predictive Value (PPV): Given test is positive, probability
that disease is present
PPV = TP/(TP + FP) or TP/(total number of positive tests)
o For example, if a computed tomography (CT) scan has 98%
specificity for appendicitis, then given a positive finding of
appendicitis, patient will truly have disease 98% of time
Negative Predictive Value (NPV): Given test is negative,
probability that the disease is absent
NPV = TN/(TN + FN) or TN/(total number of negative tests)
o For example, if an HIV test has 98% NPV, then given a negative test,
patient will truly be HIV negative 98% of time
25. Marc Imhotep Cray, M.D.
Evaluation of diagnostic tests
25
Uses 2 × 2 table comparing test results w actual presence of
disease TP, FP, TN, FN
Sensitivity and specificity are fixed properties of a test
PPV and NPV vary depending on disease prevalence in
population being tested
26. Marc Imhotep Cray, M.D.
Pre- and post-test probability
26
Pre-test probability and post-test probability (pretest and
posttest probability) are probabilities of presence of a condition
(such as a disease) before and after a diagnostic test, respectively
Post-test probability, in turn, can be positive or negative
depending on whether test falls out as a positive test or a
negative test, respectively
Ability to make a difference betw. pre- and post-test
probabilities of various conditions is a major factor in indication
of medical tests
27. Marc Imhotep Cray, M.D.
Pre- and post-test probability
cont’d.
27
Estimation of post-test probability: In clinical practice,
post-test probabilities are often just roughly estimated
This is acceptable in finding of a pathognomonic Sn or Sx in
which case it is almost certain target condition is present;
or
In absence of finding a sine qua non Sn or Sx in which case
it is almost certain target condition is absent
28. Marc Imhotep Cray, M.D.
Pre- and post-test probability
cont’d.
28
In reality, subjective probability of presence of a
condition is never exactly 0 or 100%
Yet, there are several systematic methods to estimate that
probability (eg. likelihood ratios [next slide]) methods are
based on previously having performed test on a reference
group in which presence or absence of condition is known (a
test that is considered highly accurate= "Gold standard")
o These data are used to interpret test result of any individual tested
by method
29. Marc Imhotep Cray, M.D.
Likelihood ratios (LRs) in
diagnostic testing
29
In EBM, likelihood ratios are used for assessing value of
performing a diagnostic test (=PE, Lab or other Dx study)
Use sensitivity and specificity of test to determine whether a test
result usefully changes probability that a condition (such as a
disease state) exists
Application
A likelihood ratio of greater than 1 indicates test result is associated
with disease
A likelihood ratio less than 1 indicates test result is assoc. w absence
of disease
Tests where likelihood ratios lie close to 1 have little practical
significance as post-test probability (odds) is little different from pre-
test probability
30. Marc Imhotep Cray, M.D.
Calculation of likelihood ratio
30
Two versions of likelihood ratio exist
one for positive and one for negative test results
respectively, known as
o positive likelihood ratio (LR+, likelihood ratio positive, likelihood
ratio for positive results) and
o negative likelihood ratio (LR–, likelihood ratio negative, likelihood
ratio for negative results)
Positive likelihood ratio is calculated as
which is equivalent to
Or " probability of a person who has disease testing positive divided by probability
of a person who does not have disease testing positive“
o "T+" or "T−" denote that result of test is positive or negative, respectively
o "D+" or "D−" denote that disease is present or absent, respectively
"true positives" are those that test positive (T+) and have disease (D+), and
"false positives" are those that test positive (T+) but do not have disease (D−)
31. Marc Imhotep Cray, M.D.
Calculation of likelihood ratio
cont’d.
31
Negative likelihood ratio is calculated as
which is equivalent to
or "probability of a person who has disease testing negative divided by
probability of a person who does not have disease testing negative."
Pretest odds of a particular diagnosis X multiplied by
likelihood ratio= determines post-test odds (calculation is
based on Bayes' theorem )
MKSAP Audio 1-07 – General Medicine_The Bayes Theorem (Offline)
Note : Odds can be calculated from, and then converted to, probability
32. Marc Imhotep Cray, M.D.
Likelihood ratios: Key Points
32
Likelihood ratios (LRs) are diagnostic weights= numbers
that quickly convey to clinicians how much a physical
sign argues for or against disease
LRs have possible values between 0 and ∞
o Values greater than 1 ↑probability of disease (greater value of LR,
greater ↑in probability)
LRs less than 1 decrease probability of disease (closer
number is to zero, more probability of disease ↓)
LRs that equal 1 do not change probability of disease at all
33. Marc Imhotep Cray, M.D.
LRs Key Points cont’d.
33
LRs of 2, 5, and 10 increase probability of disease about 15%,
30%, and 45%, respectively (in absolute terms)
LRs of 0.5, 0.2, and 0.1 (i.e., reciprocals of 2, 5, and 10)
decrease probability 15%, 30%, and 45%, respectively
Tables comparing LRs of different physical signs quickly inform
clinicians about which findings have greatest diagnostic value
See: Medical Likelihood Ratio Repository
The Likelihood Ratio Database
34. Marc Imhotep Cray, M.D.
Easy Estimation Table
34
Use this table to estimate how likelihood ratio changes probability without
needing a calculator
Likelihood ratios in diagnostic testing. Article is issued from WikiMed Medical Encyclopedia - version 9/28/2016.
35. Marc Imhotep Cray, M.D.
Estimation Example
35
1.Pre-test probability: For example, if about 2 out of every 5
patients with abdominal distension have ascites, then pretest
probability is 40%
2.Likelihood Ratio: An example "test" is that the physical exam
finding of bulging flanks has a positive likelihood ratio of 2.0 for
ascites
3.Estimated change in probability: Based on table of previous slide,
a likelihood ratio of 2.0 corresponds to an approximately + 15%
increase in probability
4.Final (post-test) probability: Therefore, bulging flanks increases
probability of ascites from 40% to about 55% (i.e., 40% + 15% =
55%, which is within 2% off exact probability of 57%)
36. Marc Imhotep Cray, M.D.
Calculation Example
36
An example is likelihood that a given test result would be expected in a
patient with a certain disorder compared to likelihood that same result
would occur in a patient without target disorder
A worked example: A diagnostic test w sensitivity 67% and specificity 91% is applied
to 2, 030 people to look for a disorder with a population prevalence of 1.48%
Likelihood ratios in diagnostic testing. Article is issued from WikiMed Medical Encyclopedia - version 9/28/2016.
38. Marc Imhotep Cray, M.D.
Further study:
38
Recommended textbook reading
McGee S, Steven R. Evidence-based Physical Diagnosis, 4th Ed.
Philadelphia, PA: Elsevier, 2018; 1-18.
Cloud folders
Sociology, Epidemiology/Population Health (SPH)
Interpretation of the Medical Literature (EBM)